A competency framework for clinical pharmacists and heart failure.
clinical pharmacy
continuing professional development
heart failure
pharmacists
professional practice
Journal
The International journal of pharmacy practice
ISSN: 2042-7174
Titre abrégé: Int J Pharm Pract
Pays: England
ID NLM: 9204243
Informations de publication
Date de publication:
Oct 2019
Oct 2019
Historique:
received:
07
08
2017
accepted:
01
06
2018
pubmed:
22
7
2018
medline:
11
2
2020
entrez:
21
7
2018
Statut:
ppublish
Résumé
Heart failure is an escalating 'pandemic' with malignant outcomes. Clinical pharmacist heart failure services have been developing for the past two decades. However, little clarity is available on the additional advanced knowledge, skills and experience needed for pharmacists to practice safely and competently. We aimed to provide an expert consensus on the minimum competencies necessary for clinical pharmacists to deliver appropriate care to patients with heart failure. There were four methodological parts; (1) establishing a project group from experts in the field; (2) review of the literature, including existing pharmacy competency frameworks in other specialities and previous heart failure curricula from other professions; (3) consensus building, including developing, reviewing and adapting the contents of the framework; and (4) write-up and dissemination to widen the impact of the project. The final framework defines minimum competencies relevant to heart failure for four different potential levels of specialism: all pharmacists regardless of role (Stage 1); all patient-facing clinical pharmacists (Stage 2); clinical pharmacists with specific planned roles in the care of heart failure patients (Stage 3); and regionally/nationally/internationally recognised expert pharmacists with a direct specialism in heart failure (Stage 4). The framework delivers the vital first step needed to help standardise care, give pharmacists a blueprint for career progression and continuing professional development and bring clarity to the role of the pharmacist. Future collaboration between professional bodies and training providers is needed to develop structured programmes to align with the framework and facilitate training and resultant accreditation.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
424-435Informations de copyright
© 2018 Royal Pharmaceutical Society.
Références
Ponikowski P et al. Heart failure: preventing disease and death worldwide. ESC Heart Fail 2014; 1: 4-25.
Stewart S et al. More ‘malignant’ than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail 2001; 3: 315-322.
Ambrosy PA et al. The global health and economic burden of hospitalizations for heart failure. Lessons learned from hospitalized heart failure registries. J Am Coll Cardiol 2014; 63: 1123-1133.
Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart 2007; 93: 1137-1146.
Lloyd-Jones D et al. Heart disease and stroke statistics - 2010 update: a report from the American Heart Association. Circulation 2010; 121: 948-954.
Roger VL. Epidemiology of heart failure. Circ Res 2013; 113: 646-659.
Donkor A. et al. National heart failure audit April 2014-March 2015. National Institute for Cardiovascular Outcomes Research, University College London. https://www.ucl.ac.uk/nicor/audits/heartfailure/reports/edit/documents/annualreports/annual_report_2014_15_v2 (accessed 1 June 2017)
McAlister FA et al. Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. J Am Coll Cardiol 2004; 44: 810-819.
Holland R et al. Systematic review of multidisciplinary interventions in heart failure. Heart 2005; 91: 899-906.
Ponikowski P et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2016; 37: 2129-2200.
Page RL et al. Drugs that may cause or exacerbate heart failure. Circulation 2016; 134: e32-e69.
Granger BB et al. Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial. Lancet 2005; 366: 2005-2011.
Milfred-LaForest SK et al. Clinical pharmacy services in heart failure: an opinion paper from the heart failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network. Pharmacotherapy 2013; 33: 529-548.
Brodie DC et al. Societal needs for drugs and drug related services. Am J Pharm Educ 1980; 44: 276-278.
Koshman S et al. Pharmacist care of patients with heart failure a systematic review of randomized trials. Arch Intern Med 2008; 168: 687-694.
Kang JE et al. Pharmacist-involved care for patients with heart failure and acute coronary syndrome: a systematic review with qualitative and quantitative meta-analysis. J Clin Pharm Ther 2016; 41: 145-157.
Varma S et al. Pharmaceutical care of patients with congestive heart failure: interventions and outcomes. Pharmacotherapy 1999; 19: 860-869.
Lowrie R et al. Pharmacist intervention in primary care to improve outcomes in patients with left ventricular systolic dysfunction. Eur Heart J 2012; 33: 314-324.
Bouvy ML et al. Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: a randomized controlled trial. J Card Fail 2003; 9: 404-411.
Lopez Cabezas C et al. Randomized clinical trial of a postdischarge pharmaceutical care program vs. regular follow-up in patients with heart failure. Farm Hosp 2006; 30: 328-342.
Kowal C et al. Therapy education programme in heart failure-3 year evaluation. Euro J Hosp Pharm 2016; 23: A77.
Roblek T et al. Clinical-pharmacist intervention reduces clinically relevant drug-drug interactions in patients with heart failure: a randomized, double-blind, controlled trial. Int J Cardiol 2016; 203: 647-652.
Jullion O et al. A clinical pharmacist for outpatient consultations in a heart failure clinic. Eur J Hosp Pharm Sci Pract 2013; 20: A165.
Gwadry-Sridhar FH et al. Pilot study to determine the impact of a multidisciplinary educational intervention in patients hospitalized with heart failure. Am Heart J 2005; 150: 982.
Gattis WA et al. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM). Arch Intern Med 1999; 159: 1939-1945.
Rainville EC. Impact of pharmacist interventions on hospital readmissions for heart failure. Am J Health Syst Pharm 1999; 56: 1339-1342.
Murray MD et al. Pharmacist intervention to improve medication adherence in heart failure: a randomized trial. Ann Intern Med 2007; 146: 714-725.
Stewart S et al. Effects of a home-based intervention among patients with congestive heart failure discharged from acute hospital care. Arch Intern Med 1998; 158: 1067-1072.
Roughead EE et al. The effectiveness of collaborative medicine reviews in delaying time to next hospitalization for patients with heart failure in the practice setting: results of a cohort study. Circ Heart Fail 2009; 2: 424-428.
Sadik A et al. Pharmaceutical care of patients with heart failure. Br J Clin Pharmacol 2005; 60: 183-193.
Ong KX et al. An evaluation of pharmacist-led heart failure clinic in Tan Tock Seng Hospital. J Card Fail 2011; 17(8 Suppl. 1): S109.
Kopelman P, Duggan C. The Royal Pharmaceutical Society Advanced Pharmacy Framework, Royal Pharmaceutical Society of Great Britain, 2013. https://www.rpharms.com/resources/frameworks/advanced-pharmacy-framework-apf (accessed June 2017)
Jackson S et al. An advanced pharmacy practice framework for Australia. Pharmacy 2015; 3: 13-26.
Atkinson J, Rombaut B. The 2011 PHARMINE report on pharmacy and pharmacy education in the European Union. Pharm Pract 2011; 9: 169-187.
McDonagh TA et al. Heart Failure Association of the European Society of Cardiology specialist heart failure curriculum. Eur J Heart Fail 2014; 16: 151-162.
Riley JP et al. Heart Failure Association of the European Society of Cardiology heart failure nurse curriculum. Eur J Heart Fail 2016; 18: 736-743.
Kopelman P, Duggan C. The Royal Pharmaceutical Foundation Pharmacy Framework: A framework for professional development in foundation practice across pharmacy, Royal Pharmaceutical Society of Great Britain, 2014. https://www.rpharms.com/resources/frameworks/foundation-pharmacy-framework-fpf (accessed June 2017)
Young JB et al. Task Force 8: training in heart failure. Endorsed by the Heart Failure Society of America. J Am Coll Cardiol 2008; 51: 383-389.
Young K et al. Adult Critical Care-Specialist Pharmacy Practice, Department of Health, July 2005 http://www.codeg.org/fileadmin/codeg/pdf/Critical_care_specialist_guidance.pdf (accessed June 2017).
Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Pharm Ed 1989; 53(Suppl): S7-S15.
Wong CY et al. Trends in comorbidity, disability, and polypharmacy in heart failure. Am J Med 2011; 124: 136-143.
International Pharmaceutical Federation (FIP). Advanced Practice and Specialisation in Pharmacy: Global Report 2015. The Hague: International Pharmaceutical Federation; September 2015. Report ISBN: 978-0-902936-33-1. www.fip.org/educationreports (accessed 14 June 2017).
International Pharmaceutical Federation (FIP). Pharmaceutical workforce development goals. The Hague: International Pharmaceutical Federation, November 2016. www.fip.org/educationreports (accessed June 2017)
Dalkey N, Helmer O. Delphi Technique: characteristics and sequence model to the use of experts. Manage Sci 1963; 9: 458-467.
Moher D et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. PLoS Med 2009; 6: e1000097.
McDuffie CH et al. Web-based portfolios for pharmaceutical care plans during advanced pharmacy practice experiences. Am J Pharm Educ 2010; 74: 59.
McKenzie C et al. Developing a process for credentialing advanced level practice in the pharmacy profession using a multi-source evaluation tool. Pharm J 2011; 286: 543.
Excellence by design: standards for postgraduate curricula. General Medical Council. 22 May 2017. www.gmc-uk.org/education/postgraduate/standards_for_curricula.asp (accessed April 2018)
Anderson C et al. The WHO UNESCO FIP Pharmacy Education Taskforce. Hum Resour Health 2009; 7: 45.
The European statements of hospital pharmacy. Euro J Hosp Pharm Sci Pract 2014; 21: 256-258.
Clark AM et al. A qualitative study of the contribution of pharmacists to heart failure management in Scotland. Pharm World Sci 2005; 27: 453-458.
Ogrinc G et al. SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process. BMJ Qual Saf 2016; 25: 986-992.
Brouwers MC et al. AGREE Next Steps Consortium. The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines. BMJ 2016; 352: i1152.